Albumin-Bilirubin (ALBI) and Monocyte to Lymphocyte Ratio (MLR)-Based Nomogram Model to Predict Tumor Recurrence of AFP-Negative Hepatocellular Carcinoma

MLA

Xi Yu, et al. “Albumin-Bilirubin (ALBI) and Monocyte to Lymphocyte Ratio (MLR)-Based Nomogram Model to Predict Tumor Recurrence of AFP-Negative Hepatocellular Carcinoma.” Journal of Hepatocellular Carcinoma, Nov. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....1b94273e39d7a30c84123ee47dc2c9c4&authtype=sso&custid=ns315887.

APA

Xi Yu, Caide Lu, Yuying Shan, Shuqi Mao, Rui Fan, & Shengdong Wu. (2021). Albumin-Bilirubin (ALBI) and Monocyte to Lymphocyte Ratio (MLR)-Based Nomogram Model to Predict Tumor Recurrence of AFP-Negative Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma.

Chicago

Xi Yu, Caide Lu, Yuying Shan, Shuqi Mao, Rui Fan, and Shengdong Wu. 2021. “Albumin-Bilirubin (ALBI) and Monocyte to Lymphocyte Ratio (MLR)-Based Nomogram Model to Predict Tumor Recurrence of AFP-Negative Hepatocellular Carcinoma.” Journal of Hepatocellular Carcinoma, November. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....1b94273e39d7a30c84123ee47dc2c9c4&authtype=sso&custid=ns315887.